Results 11 to 20 of about 21,695 (218)
Hybrid rotablation and drug-eluting balloon strategy. [PDF]
Cardiovasc J Afr, 2021 The aim was to assess the safety and efficacy of rotational atherectomy followed by drug-eluting balloon (DEB) in patients with a high risk of bleeding.A retrospective review was carried out of hospital records of consecutive patients who underwent the hybrid procedure.The average age of the 23 patients was 74 years.
Vachiat A, Ntsekhe M, Hellig F.
europepmc +4 more sources
Archives of Medical Science: Atherosclerotic DiseasesIntroduction Several treatment modalities have been proposed and used for bare-metal in-stent restenosis (ISR). We compared the efficacy of drug-eluting balloons (DEB) versus drug-eluting stents (DES) in the treatment of ISR in terms of binary restenosis,
Neeraj Mahajan +2 more
doaj +3 more sources
Circulation: Cardiovascular Interventions, 2009 Balloon angioplasty revolutionized coronary revascularization; however, elastic recoil and restenosis caused by cellular proliferation are major drawbacks of angioplasty. Intracoronary stenting, which could tackle dissections and eliminate elastic recoil, became the next mode of intervention but was limited by stent thrombosis and increased neointimal ...
Ron, Waksman, Rajbabu, Pakala
openaire +2 more sources
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis. [PDF]
Coron Artery Dis, 2019 Approximately, 10-20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown. We sought to compare the outcomes of recurrent DES-ISR treated with drug eluting balloons (DEB) to those with repeated implantation of new-generation DES.A total of 172 ...
Wang G +5 more
europepmc +4 more sources
A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]
, 2016 Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L. +4 more
core +2 more sources
Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. [PDF]
, 2014 Cardiovascular disease remains one of the largest contributors to death worldwide. Improvements in cardiovascular technology leading to the current generation of drug-eluting stents, bioresorbable stents, and drug-eluting balloons, coupled with advances ...
Panitch, Alyssa, Scott, Rebecca A
core +2 more sources
Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
Indian Heart Journal, 2014 The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is still not well defined. Various treatment modalities include plain old balloon angioplasty (POBA), metallic stent, cutting or scoring balloon and drug ...
Surender Deora +3 more
doaj +1 more source
Understudied factors in drug‐coated balloon design and evaluation: A biophysical perspective
Bioengineering & Translational Medicine, 2023 Drug‐coated balloon (DCB) percutaneous interventional therapy allows for durable reopening of the narrowed lumen via physical tissue expansion and local anti‐restenosis drug delivery, providing an alternative to traditional uncoated balloons or a ...
Tarek Shazly +5 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundCoronary bifurcation lesions are common of percutaneous coronary intervention (PCI), and the optimal interventional therapy strategy is still a matter of debate and remains a challenge for interventional cardiologists.
Haoyu Wu +7 more
doaj +1 more source
Trials, 2012 Background Neointimal hyperplasia plays a pivotal role in the pathogenesis of in-stent restenosis in patients undergoing percutaneous coronary interventions.
Burzotta Francesco +10 more
doaj +1 more source